US Patent Issued to Astellas Pharma, Kotobuki Pharmaceutical on June 16 for "Heteroaryl carboxamide compound" (Japanese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,122, issued on June 16, was assigned to Astellas Pharma Inc. (Tokyo) and Kotobuki Pharmaceutical Co. Ltd. (Nagano, Japan).

"Heteroaryl carboxamide compound" was invented by Hideyuki Watanabe (Tokyo), Takashi Kamikubo (Tokyo), Akio Kamikawa (Tokyo), Takuya Washio (Tokyo), Yohei Seki (Tokyo), Keiichiro Okuyama (Tokyo), Osamu Ikeda (Tokyo), Hiroshi Tomiyama (Nagano, Japan), Yoshinori Iwai (Nagano, Japan), Akihiko Nakamura (Nagano, Japan) and Kozo Miyasaka (Nagano, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are heteroaryl carboxamide compounds which have a DGK Xi (DGKzeta) inhibitory effect. The compounds described herein are u...